Schedule 13D ownership disclosure
Voyager Therapeutics Inc
Security class unavailable · CUSIP: 92915B106
Event date: 2023-02-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-047416
- Form type
- SC 13D
- Filer
- NEUROCRINE BIOSCIENCES INC
- CIK
- CIK 914475
- Filed
- Feb 24, 2023
- Reporting period
- Feb 23, 2023
- Description
- Schedule 13D beneficial ownership